- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-01-0016585

About Aconwell Pharma Private Limited
Data last updated:
Aconwell Pharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2019PTC081592. Its GSTIN is 06AASCA5337R1ZV (Haryana).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Rocky and Reena Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Khasra No.8//14//9 Arjun Nagar, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.61 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹8.27 Lakh (net margin 1.1%) and EBITDA of ₹41.08 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years.
As per MCA filings, the company has open charges of ₹60 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 2 cases are pending.
Aconwell Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0016585). For more details, the company can be reached via its website pharmahopers.com.
Company details
Recognitions & Rankings of Aconwell Pharma
Contact details
Aconwell Pharma Private Limited's registered office is in Ambala Cantt, Haryana. Its website is pharmahopers.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor Khasra No.8//14//9 Arjun Nagar, Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aconwell Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aconwell Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aconwell Pharma Private Limited, buy the company report.
Financials of Aconwell Pharma Private Limited
FY 2025 filings availableAconwell Pharma Private Limited reported revenue of ₹7.61 Cr (up 21% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over three years, including 21% growth in the latest year. EBITDA rose 125% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aconwell Pharma Private Limited, buy the company report.
Board of directors of Aconwell Pharma Private Limited
Aconwell Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rocky Also directs: Alfavision Biotech Private Limited | Director | 22 Jul 2019 | 7 Years 3 Months | Current |
| Reena Rani Also directs: Watran Pharmaceuticals Private Limited | Director | 23 Jun 2025 | 1 Years 4 Months | Current |
| Neha Rani | Director | 30 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Aconwell Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stone Polymers Private Limited | ₹7.62 Cr (FY 2017) | 155.0% | Mumbai, Maharashtra, India | |||
| Gulabo Mart Private Limited | ₹7.62 Cr (FY 2025) | -18.0% | Bathinda, Punjab, India | |||
| Shree Ambica Exim Private Limited | ₹7.62 Cr (FY 2024) | 26.0% | Siliguri, West Bengal, India | |||
| Desbro Enterprises (India) Private Limited | ₹7.61 Cr (FY 2025) | 18.0% | Tiswadi, Goa, India | |||
| Chetan Das Om Prakash Impex Private Limited | ₹7.61 Cr (FY 2024) | 11.0% | Delhi, India | |||
| Aconwell Pharma Private Limitedthis company | ₹7.61 Cr (FY 2024) | ₹8.27 Lakh | 1.1% | 21.0% | Ambala Cantt, Haryana, India | |
| Gwhome Private Limited | ₹7.61 Cr (FY 2025) | -16.0% | Agra, Uttar Pradesh, India | |||
| Gladios Products Private Limited | ₹7.61 Cr (FY 2024) | -13.0% | Gandhinagar, Gujarat, India | |||
| M Metal-Tubes India Private Limited | ₹7.61 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Maya Synthetics Private Limited | ₹7.61 Cr (FY 2024) | -40.0% | Surat, Gujarat, India | |||
| Narayanan Manikantan Traders Private Limited | ₹7.61 Cr (FY 2021) | -9.0% | Thiruvananthapuram, Kerala, India |
To see the full peer comparison of Aconwell Pharma Private Limited, buy the company report.
Auditor
Aconwell Pharma Private Limited is audited by GOYAL JYOTI & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOYAL JYOTI & COMPANY | FY 2023 | 032667N |
Shareholding
The shareholding of Aconwell Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Aconwell Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2025 | 101116460 | State Bank of India | ₹60 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Aconwell Pharma Private Limited has 2 court cases on record: 2 filed by Aconwell Pharma. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against M/S Riya Medical Agency | Pending |
| District court, Ambala, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Aconwell Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aconwell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aconwell Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AASCA5337R1ZV | Haryana | Active | 08 Aug 2019 |
To see the full GST registrations and return filing status of Aconwell Pharma Private Limited, buy the company report.
Recent activity
Aconwell Pharma Private Limited has 9 board changes on record since 2019: 6 appointments and 3 cessations. The latest: Reena Rani was appointed as Director on 23 Jun 2025.
1 earlier event is in the company report.
Frequently asked questions
Aconwell Pharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 July 2019 (7+ years old) and is registered under CIN U24290HR2019PTC081592.
Aconwell Pharma has 3 current directors:
- Rocky - Director
- Reena Rani - Director
- Neha Rani - Director
The latest financial statements of Aconwell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Aconwell Pharma is 06AASCA5337R1ZV, registered in Haryana.
The CIN (Corporate Identification Number) of Aconwell Pharma is U24290HR2019PTC081592. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aconwell Pharma has 2 court cases on record: 2 filed by the company. 2 are pending.
Aconwell Pharma was incorporated on 22 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Aconwell Pharma by revenue are Stone Polymers Private Limited, Gulabo Mart Private Limited, Shree Ambica Exim Private Limited, Desbro Enterprises (India) Private Limited, Chetan Das Om Prakash Impex Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Reena Rani was appointed as Director on 23 Jun 2025. Vashist Sandhu ceased to be Director on 31 Jul 2024. Neha Rani was appointed as Director on 30 Jul 2024. Aconwell Pharma has 9 board changes on record in total.
Yes, Aconwell Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-01-0016585).
Aconwell Pharma can be reached through the website pharmahopers.com. Its registered office is in Ambala Cantt, Haryana, India.

